Several recent studies15, -17 have explored the role of AI in GDM, with models achieving high accuracy in predicting GDM onset based on maternal risk factors, optimizing insulin therapy, and improving continuous glucose monitoring via wearable devices and mobile health (mHealth) applications. This evidence concerns the gene INS and gestational diabetes.